Mcf Advisors LLC Bristol Myers Squibb CO Transaction History

Mcf Advisors LLC

$1.42 Billion
Q3 2024

A detailed history of Mcf Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mcf Advisors LLC holds 7,135 shares of BMY stock, worth $419,395. This represents 0.03% of its overall portfolio holdings.

Number of Shares

7,135

Previous 7,109 0.37%

Holding current value

$419,395

Previous $295,000 25.08%

% of portfolio

0.03%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$39.66 - $51.75 $1,031 - $1,345	26 Added 0.37%	7,135 $369,000
Q2 2024 Aug 05, 2024	SELL	$40.25 - $52.99 $11,189 - $14,731	-278 Reduced 3.76%	7,109 $295,000
Q1 2024 Apr 16, 2024	SELL	$47.98 - $54.4 $8,156 - $9,248	-170 Reduced 2.25%	7,387 $400,000
Q4 2023 Feb 01, 2024	BUY	$48.48 - $57.85 $1,308 - $1,561	27 Added 0.36%	7,557 $387,000
Q3 2023 Oct 19, 2023	BUY	$57.89 - $64.73 $7,699 - $8,609	133 Added 1.8%	7,530 $437,000
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $2 - $1,690	-22 Reduced 0.3%	7,397 $526,000
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $36,310 - $39,990	500 Added 7.23%	7,419 $573,000
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $425,380 - $510,068	6,919 New	6,919 $505,000
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $374,605 - $436,702	-6,985 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $5,266 - $6,168	89 Added 1.29%	6,985 $413,000
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $82,340 - $89,668	1,330 Added 23.9%	6,896 $461,000
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $46,581 - $52,390	-785 Reduced 12.36%	5,566 $351,000
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $6,776 - $7,509	118 Added 1.89%	6,351 $383,000
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $37,005 - $48,270	752 Added 13.72%	6,233 $400,000
Q1 2019 May 07, 2019	SELL	$45.12 - $53.8 $37,855 - $45,138	-839 Reduced 13.28%	5,481 $261,000
Q4 2018 Jan 25, 2019	BUY	$48.76 - $63.23 $243 - $316	5 Added 0.08%	6,320 $329,000
Q3 2018 Oct 24, 2018	BUY	$55.19 - $62.25 $220 - $249	4 Added 0.06%	6,315 $392,000
Q2 2018 Jul 20, 2018	SELL	$50.53 - $62.98 $38,554 - $48,053	-763 Reduced 10.79%	6,311 $349,000
Q1 2018 May 10, 2018	SELL	$59.92 - $68.98 $127,629 - $146,927	-2,130 Reduced 23.14%	7,074 $447,000
Q4 2017 Feb 06, 2018	BUY	$59.94 - $65.35 $1,498 - $1,633	25 Added 0.27%	9,204 $564,000
Q3 2017 Oct 30, 2017	BUY	$55.23 - $63.74 $506,956 - $585,069	9,179	9,179 $585,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mcf Advisors LLC with notifications on news.

Account